These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 681005)

  • 21. Comparison of the thrombolytic efficacy of defibrase and urokinase on canine coronary artery thrombosis and the mechanism of urokinase-induced hemorrhage.
    Huang DX; Song A; Yang X; Wang S
    Acta Cardiol; 1987; 42(4):249-61. PubMed ID: 3499037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dilution of urokinase used to treat thrombus formation in central venous catheters.
    Wiseman KC
    ANNA J; 1997 Aug; 24(4):457-8. PubMed ID: 9325699
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and antithrombogenicity of polyetherurethaneurea containing quaternary ammonium groups in the side chains and of the polymer/heparin complex.
    Ito Y; Sisido M; Imanishi Y
    J Biomed Mater Res; 1986 Sep; 20(7):1017-33. PubMed ID: 3760001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A femoral vein catheter with immobilized urokinase (UKFC) as an antithrombotic blood access.
    Kitamoto Y; Fukui H; Iwabuchi K; Taguma Y; Monma H; Ishizaki M; Takahashi H; Nakayama M; Sekino H
    ASAIO Trans; 1987; 33(3):136-9. PubMed ID: 3675935
    [No Abstract]   [Full Text] [Related]  

  • 25. [Activation of plasminogen and prothrombin by immobilized activators -- urokinase and thromboplastin (author's transl)].
    Rybák M; Coupek J
    Cas Lek Cesk; 1980 Oct; 119(40-41):1106-8. PubMed ID: 7026035
    [No Abstract]   [Full Text] [Related]  

  • 26. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
    Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
    J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of urokinase from complex mixtures using immobilized monoclonal antibody against urokinase light chain.
    Vetterlein D; Calton GJ
    Thromb Haemost; 1983 Feb; 49(1):24-7. PubMed ID: 6342200
    [No Abstract]   [Full Text] [Related]  

  • 28. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis.
    Collen D; Stassen JM; Blaber M; Winkler M; Verstraete M
    Thromb Haemost; 1984 Aug; 52(1):27-30. PubMed ID: 6541817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urokinase therapy for thrombosis of tricuspid prosthetic valve.
    Joyce LD; Boucek M; McGough EC
    J Thorac Cardiovasc Surg; 1983 Jun; 85(6):935-7. PubMed ID: 6343730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enzymatic fibrinolytic agents].
    Jamet M; Granthil C; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):693-6. PubMed ID: 31112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrophilic-hydrophobic microdomain surfaces having an ability to suppress platelet aggregation and their in vitro antithrombogenicity.
    Okano T; Aoyagi T; Kataoka K; Abe K; Sakurai Y; Shimada M; Shinohara I
    J Biomed Mater Res; 1986 Sep; 20(7):919-27. PubMed ID: 3760008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of human recombinant tissue-type plasminogen activator and urokinase in microsurgical thrombolysis in the rat.
    Levy EA; Sadove AM; Eppley BL; Evan AP
    J Reconstr Microsurg; 1991 Jul; 7(3):209-16. PubMed ID: 1909760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A natural rubber drainage tube with antithrombogenic lumen surface.
    Klöcking HP; Schunk W; Merkmann G; Giessmann C; Knoll H; Borgmann S
    Thromb Res; 1993 Dec; 72(6):501-7. PubMed ID: 7510427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aortic thrombosis in a neonate: failure of urokinase thrombolytic therapy.
    Corrigan JJ; Jeter M; Allen HD; Malone JM
    Am J Pediatr Hematol Oncol; 1982; 4(3):243-7. PubMed ID: 6756190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical study of urokinase-bound fibrocollagenous tubes.
    Senatore F; Bernath F; Meisner K
    J Biomed Mater Res; 1986 Feb; 20(2):177-88. PubMed ID: 2937788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fibrinolytic therapy of deep venous thrombosis. Streptokinase, urokinase, plasminogen substitution].
    Theiss W; Kriessmann A; Wirtzfeld A
    Dtsch Med Wochenschr; 1980 Feb; 105(8):243-6. PubMed ID: 6986252
    [No Abstract]   [Full Text] [Related]  

  • 38. Urokinase immobilized on erythrocytes.
    Kitao T; Hattori K
    Thromb Haemost; 1980 Feb; 43(1):70. PubMed ID: 6996207
    [No Abstract]   [Full Text] [Related]  

  • 39. Application of immobilized enzymes for biomaterials used in surgery.
    Watanabe S; Shimizu Y; Teramatsu T; Murachi T; Hino T
    Methods Enzymol; 1988; 137():545-51. PubMed ID: 3374358
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on a plasminogen activating system in human milk: IV. Difference in the binding to fibrin between human milk plasminogen activator (mild activator) and urokinase (author's transl)].
    Horie N
    Nihon Ketsueki Gakkai Zasshi; 1979 Oct; 42(5):38-45. PubMed ID: 396753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.